臨床試験・研究

ホーム　＞　臨床試験・研究　＞　論文　＞2025年

論文

過去の論文

2025年

英文論文

  • Akita M, Yanagimoto H, Tsugawa D, Zen Y, Fukumoto T. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review. Surg Today 55:1-9　（2025年1月）
  • Kusuhara T, Gon H, Terashima K, Komatsu S, Matsuo Y, Tokumaru S, Toyama H, Kido M, Okimoto T, Fukumoto T. ASO Author Refections: The potential role of particle therapy as a therapeutic option for patients with recurrent hepatocellular carcinoma after liver resection. Ann Surg Oncol. 32(1):448-449（2025年1月）
  • Okuno T, Morizane C, Mizusawa J, Yanagimoto H, Kobayashi S, Imaoka H, Terashima T, Kawakami H, Sano Y, Okusaka T, Ikeda M, Ozaka M, Miwa H, Todaka A, Shimizu S, Mizuno N, Sekimoto M, Sano K, Tobimatsu K, Katanuma A, Gotoh K, Yamaguchi H, Ishii H, Furuse J, Ueno M. Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113. Int J Clin Oncol. 30(1):83-91（2025年1月）
  • Kiyasu Y, Poudel S, Koike D, Watanabe J, Kowatari R, Fukumoto M, Yamaoka-Fujikawa Y, Kikuchi Y, Arai K, Booka E, Ishida S, Yokoyama S, Saito M. Current status of the surgical training system in Japan: results of a nationwide questionnaire survey of graduating surgical trainees. Surg Today. 55(1):90-98（2025年1月）
  • Ishihara N, Komatsu S, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Matsuura T, Tada T, Kodama Y, Fukumoto T．Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma. Anticancer Res．　45(1):251-260（2025年1月）
  • Gon H, Omiya S, Komatsu S, Yamasaki N, Murakami S, Fukushima K, Urade T, Tsugawa D, Yanagimoto H, Toyama H, Kido M, Fukumoto T. Efficacy and safety of indocyanine green-fluorescence imaging guided liver resection: a single-arm prospective cohort study．　Langenbecks Arch Surg.　410(1):34　（2025年1月）
  • Gon H, Komatsu S, Soyama H, Tanaka M, Kido M, Fukushima K, Urade T, So S, Yoshida T, Arai K, Tsugawa D, Yanagimoto H, Toyama H, Fukumoto T. Impact of depth of body cavity at the upper-right portion of the abdomen on open and laparoscopic liver resection of segment 7. Langenbecks Arch Surg. 410(1):37（2025年1月）
  • Kusuhara T, Gon H, Terashima K, Komatsu S, Matsuo Y, Tokumaru S, Toyama H, Kido M, Okimoto T, Fukumoto T. Comparison of Prognostic Outcomes Between Repeat Liver Resection and Particle Therapy for Patients with Recurrent Hepatocellular Carcinoma. Ann Surg Oncol. 32(2):1073-1082（2025年２月）
  • Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Toyama H, Kido M, Fukumoto T. Anomalous origin of the posterior superior pancreaticoduodenal artery: critical vascular variations in the field of hepato-pancreato-biliary surgery. J Gastrointest Surg. 29(2): 101926（2025年2月）
  • Inoue Y, Yano Y, Kushida S, Hirohata S, Yoon S, Yasutomi E, Hirano H, Kim SK, Yoshida R, Ueda Y, Momose K, Hayashi H, Kado T, Nishi K, Tanaka H, Matono T, Yamamoto A, Tei H, Nishioka C, Yagi Y, Tamura S, Sakane T, Ehara M, Kawano M, Kitadai J, Matsuura T, Shiomi Y, Komatsu S, Fukumoto T, Tada T．Higher Absolute Lymphocyte Counts and Lower Des-γ-Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma. JGH Open. 9(2): e70123（2025年2月）
  • Komatsu S, Yano Y, Ishihara N, Kido M, Gon H, Fukushima K, Urade T, Yanagimoto H, Toyama H, Fukumoto T. Treatment outcomes of hepatectomy and systemic chemotherapy based on oncological resectability criteria for hepatocellular carcinoma. Ann Gastroenterol Surg. 9(2):235-243（2025年3月）
  • Nanno Y, Toyama H, Nagai K, Lee D, Uchida Y, Ishida J, Takahara T, Matsumoto I, Hatano E, Fukumoto T. Endoscopic ultrasound-guided tissue acquisition allows a reliable proliferation assessment of small (≤20 mm) pancreatic neuroendocrine tumors．Ann Gastroenterol Surg. 9(2):339-346（2025年3月）
  • Ishihara N, Koma Y, Omori M, Komatsu S, Torigoe R, Yokoo H, Nakanishi T, Yamanaka K, Azumi Y, Tsukamoto S, Kodama T, Nishio M, Shigeoka M, Yokozaki H, Fukumoto T. Chemokine (C-C Motif) Ligand 2/CCR2/Extracellular Signal-Regulated Kinase Signal Induced through Cancer Cell-Macrophage Interaction Contributes to Hepatocellular Carcinoma Progression. Am J Pathol. 195(3):589-608（2025年3月）
  • Urade T, Tsuchida S, Oji K, Fujiwara Y, Fukuoka Y, Yasuda T, Fukumoto T. Development of a novel fluorescent gauze using indocyanine green. Sci Rep. 15: 10189（2025年3月）
  • Ueshima E, Sofue K, Komatsu S, Ishihara N, Komatsu M, Umeno A, Nishiuchi K, Kozuki R, Yamaguchi T, Matsuura T, Tada T, Murakami T. Immunoscore Predicted by Dynamic Contrast-Enhanced Computed Tomography Can Be a Non-Invasive Biomarker for Immunotherapy Susceptibility of Hepatocellular Carcinoma. Cancers (Basel). 17(6):948（2025年3月）
  • Oji K, Urade T, Omiya S, Kido M, Komatsu S, Gon H, Fukushima K, Yanagimoto H, Toyama H, Fukumoto T. Achieving textbook outcome in liver resection for hepatocellular carcinoma: malnutrition's pivotal role. Langenbecks Arch Surg. 410:139（2025年4月）
  • Shimura Y, Komatsu S, Hashimoto Y, Nishio M, Hashimoto Y, Yoshida M, Yoshida T, Fukushima K, Fujita I, Fukumoto T．Biomarker-guided strategy for Denver peritoneovenous shunts in refractory ascites: a retrospective single-center study. Langenbecks Arch Surg. 410:140（2025年4月）
  • Mizumoto T, Toyama H, Nanno Y, Ishida J, Uchida Y, Iwama H, Kojima M, Takahara T, Suda K, Fukushima K, Gon H, Komatsu S, Yanagimoto H, Kido M, Fukumoto T. Impact of a dilated main pancreatic duct in the expected remnant pancreas on the incidence of clinically significant remnant pancreatic lesion after resection of noninvasive and microinvasive intraductal papillary mucinous neoplasms. Pancreatology 25(3):440-449（2025年4月）
  • Shindoh J, Shindoh J, Matsumura M, Komatasu S, Fukumoto T, Ichida A, Hasegawa K, Ishii T, Hatano E, Nakamura M, Ohtsuka M. Prognostic factors and clinical significance of preoperative systemic therapy in patients with borderline resectable hepatocellular carcinoma: A JSHBPS project study 2023, Part 2. J Hepatobiliary Pancreat Sci. 32(5):374-384（2025年5月）
  • Uno R, Zen Y, Tanaka T, Toyama H, Fukumoto T, Sofue K, Itoh T. A Potential Case of Tubulocystic Ductal Carcinoma of the Pancreas. Pathol Int. 75(5):243-246（2025年5月）
  • Komatsu S, Nagamata S, Terashima K, Demizu Y, Suga M, Kido M, Yanagimoto H, Toyama H, Tokumaru S, Okimoto T, Terai Y, Fukumoto T. Combination Treatment with Spacer Placement Surgery Followed by Particle Radiotherapy for Lymph Node Metastasis from Uterine Cancer. Ann Surg Oncol. 32(6):4313-4321(2025年6月)
  • Mizumoto T, Nanno Y, Ishida J, Lee D, Fukushima K, Komatsu S, Yanagimoto H, Asari S, Kido M, Fukumoto T. Prognostic Significance of GLIM-Defined Malnutrition in Patients With Resectable Pancreatic Adenocarcinoma Following Upfront Surgery, Prognostic Significance of GLIM-Defined Malnutrition in Patients With Resectable Pancreatic Adenocarcinoma Following Upfront Surgery. Ann Gastroenterol Surg. 9(6):1351-1361 （2025年6月）
  • Ishida J, Toyama H, Nanno Y, Mizumoto T, Komatsu S, Yanagimoto H, Kido M, Fukumoto T. Robotic pancreaticoduodenectomy for portal annular pancreas: how to do it. Surg Today. 55(7):1004-1007（2025年７月）
  • Komatsu S, Yano Y, Twrashima K, Fujishima Y, Ishida J, Ishihara N, Matsuura T, Okimoto T, Kodama T, Fukumoto T. The potential efficacy of atezolizumab plus bevacizumab treatment for hepatocellular carcinoma patients with macroscopic portal vein tumor thrombus. Surg Today. 55(7):900-908（2025年7月）
  • Yamazaki H, Yamazaki H, Kimoto T, Teramukai S, Nakata M, Shibuya K, Suzuki M, Terashima K, Iizumi T, Wakatsuki M, Hashimoto T, Fukumoto T, Ohtsuka M. Role of Particle Beam Therapy for Extrahepatic Biliary Cancer-Updated Systematic Review and Meta-Analysis for Comparison Between Photon and Particle Radiotherapy. J Hepatobiliary Pancreat Sci. 32(7):506-513（2025年7月）
  • Yamazaki H, Shibuya K, Kimoto T, Suzuki M, Murakami M, Terashima K, Okimoto T, Izumi T, Sakurai H, Watatsuki M, Ogino T, Arimura T, Takagi M, Araya M, Waki T, Matsumoto S, Ogino H, Katoh N, Hashimoto T, Hojo H, Fukumitsu N, Fukumoto T, Ohtuka M. Sci Rep. 15(1):23250（2025年7月）
  • Takimoto D, Ishida J, Toyama H, Nanno Y, Mizumoto T, Yoshida T, Urade T, Fukushima K, Gon H, Tsugawa D, Komatsu S, Yanagimoto H, Kido M, Fukumoto T. Usefulness of A Portal Vein Stent for Sinistral Portal Hypertension: A Case Report. Surg Case Rep. 11(1): 25-0206（2025年7月）
  • Ishihara N, Komatsu S, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yanagimoto H, Toyama H, Kodama Y, Fukumoto T. Multidisciplinary strategies including local treatment to achieve drug-free status after atezolizumab plus bevacizumab treatment in hepatocellular carcinoma. Oncol Lett. 45(8): e70217 （2025年7月）
  • Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Tamai H, Matsuura T, Komatsu S, Ueda Y, Nakamura Y, Yoshida O, Nakamura S, Enomoto H, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Pancreatology． 25(5):667-675 （2025年8月）
  • Miura T, Watanabe A, Miyake M, Suga S, Miyoshi M, Miyashita K, Komatsu S, Nishimura N, Shimizu K, Hori Y. Novel orthotopic patient-derived xenograft model using human pancreatic cancer tissue fragments to recapitulate distant metastasis and cancer-related hypercoagulability. Med Mol Morphol. 58(3):183-192　（2025年9月）
  • Kajihara A, Demizu Y, Iwashita K, Park S, Fukumitsu N, Tokumaru S, Takahashi D, Matsuo Y, Terashima K, Okimoto T, Seno S, Ishihara T, Miyawaki D, Komatsu S, Chen YW, Fukumoto T, Sasaki R. Space-making Particle Therapy Using Bioabsorbable Spacer for Bone and Soft Tissue Sarcomas: Two-institution Experience. Anticancer Res. 45(9):3785-3794（2025年9月）
  • Konaka R, Yanagimoto H, Tsugawa D, Akita M, Mizumoto T, Yoshida T, So S, Ishida J, Nanno Y, Urade T, Fukushima K, Gon H, Komatsu S, Asari S, Kido M, Toyama H, Fukumoto T. GLIM Criteria as Prognostic Factor in Patients Undergoing Adjuvant S-1 Chemotherapy for Biliary Tract Cancer. Cancer Diagn Progn. 5(5):557-565 （2025年9月）
  • Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai MM, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Tamai H, Matsuura T, Komatasu S, Ueda Y, Nakamura Y, Yoshida O, Nakamura S, Enomoto H, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab. Hepatol Res. 55(9):1285-1295（2025年9月）
  • Gon H, Fujisawa A, Komatsu S, Tanaka M, Fukushima K, Urade T, Yoshida T, Arai K, Ishida J, Nanno Y, Tsugawa D, Yanagimoto H, Toyama H, Kido M, Fukumoto T. Comparison of the surgical difficulty between segment 7 and 8 partial liver resection untilizing the laparoscopic and open approaches． Surg Today. 55(10):1383-1392（2025年10月）
  • Sofue K, Ueno Y, Yabe S, Ueshima E, Yamaguchi T, Masuda A, Sakai A, Tomaya H, Fukumoto T, Hori M, Murakami T. Advantages of deep learning reconstruction algorithm in ultra-high-resolution CT for the diagnosis of pancreatic cystic neoplasm. Jpn J Radiol.　43(10):1652-1662（2025年10月）
  • Komatsu S, Tada T, Terashima K, Ishihara N, Omori M, Matsuura T, Ueshima E, Sofue K, Kodama Y, Fukumoto T. Utilizing the Conversion Concept Based on Disease Status Following Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma. World J Surg. 49(10):2854-2862（2025年10月）
  • Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Mizumoto T, Yoshida T, So S, Ishida J, Urade T, Nanno Y, Fukushima K, Gon H, Komatsu S, Asari S, Toyama H, Kido M, Fukumoto T. Using the comprehensive complication index to assess the impact of Global Leadership Initiative on Malnutrition (GLIM)-defined malnutrition on postoperative complications after resection for biliary tract cancer. Surg Today. 55(11):1598-1608（2025年11月）
  • Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Noritake H, Ohama H, Tada F, Nouso K, Morishita A, Tsutui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Tamai H, Matsuura T, Komatsu S, Ueda Y, Nakamura Y, Yoshida O, Matsui K, Nakamura S, Enomoto H, Yoshida O, Matsui K, Nakamura S, Enomoto H, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Real‐life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts From 48 Clinics in Japan (HCC 48) Group. Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis. Hepatol Res. 55(11):1507-1517 （2025年11月）
  • Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Tamai H, Komatsu S, Tada F, Nakamura S, Nakamura Y, Miyake T, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Tanaka K, Matsuura T, Koshiyama Y, Kanayama Y, Noritake H, Enomoto H, Matsui K, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Kumada T, RELPEC Group and HCC 48 Group. Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma. J Gastroenterol. 60(11):1427-1436（2025年11月）
  • Oji K, Urade T, Omiya S, Kido M, Komatsu S, Fukushima K, So S, Yoshida T, Tai K, Arai K, Iguchi K, Lee D, Akita M, Mizumoto T, Ishida J, Nanno Y, Asari S, Yanagimoto H, Fukumoto T. Impact of malnutrition on short- and long-term outcomes following laparoscopic liver resection for hepatocellular carcinoma. Mini-invasive Surg. 9(25):1-15 （2025年11月）
  • Ueshima E, Sofue K, Kodama T, Yamamoto S, Komatsu M, Komatsu S, Ishihara N, Umeno A, Yamaguchi T, Hori M, Fukumoto T, Takehara T, Murakami T. Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features Can Predict Immune-Excluded Phenotype of Hepatocellular Carcinoma. Liver Cancer. 14:271-285 （2025年）
  • Takahashi T, Komatsu S, Demizu Y, Arai S, Ishihara N, Gfujisawa A, Gon H, Toyma H, Tokumaru S, Fukumoto T. A Case of Unresectable Hepatocellular Carcinoma Treated with Spacer Placement Surgery with Bioabsorbable Spacer and Subsequent Proton Beam Therapy. Surg Case Rep. 11(1): 25-0026 （2025年）
  • Matsumoto S, Asari S, Nanno Y, Nakamura H, Okawa T, Fukumoto T. Donor Pigs for Clinical Islet Xenotransplantation: Review and Future Directions. Cell Transplant. 34:1-11　（2025年1月～12月）
  • Oji K, Urade T, Bo R, Kido M, Komatsu S, Gon H, Fukushima K, So S, Yoshida T, Tai K, Arai K, Fukumoto T. Laparoscopic Liver Resection for Hepatocellular Adenomas in Pediatric Glycogen Storage Disease Type Ia: A Case With Consideration for Future Transplantation. Asian J Endosc Surg. 18(1): e70090　（2025年1月～12月）

邦文論文

  • 柳本　泰明：胆道癌に対する薬物療法 消化器外科 48(2):175-180, 2025
  • 小松　昇平, 出水　祐介, 福本　巧：後腹膜腫瘍に対するスペーサー手術+粒子線治療の現状 手術 79(3):339-344 2025
  • 石田　潤, 外山　博近, 南野　佳英, 水本　拓也, 李　東河, 福本　巧：開腹膵体尾部切除術 手術 79(4):615-623 2025
  • 大森　將貴, 小松　昇平, 石原　伸朗, 寺嶋　千貴, 木戸　正浩, 権　英寿, 福島　健司, 浦出　剛史, 沖本　智昭, 福本　巧：アテゾリズマブ＋ベバシズマブ併用療法後に粒子線治療および肝切除を施行しcancer freeを達成しえた高度門脈腫瘍栓合併肝細胞癌の1例 日本消化器外科学会雑誌 58(5):286-294 2025
  • 西野　裕人, 小木曾　聡, 波多野　悦郎, 浦出　剛史：第III章　ICG肝切除の問題点：Pros ＆ Cons 腹腔鏡下肝切除術　ロボット支援下手術とICGナビゲーション １66-172 2025
  • 福本　巧：新人外科医の確保, 現役外科医ができること 外科 87(9):986 2025
  • 小松　昇平：子宮癌リンパ節転移に対するスペーサー留置術および粒子線治療の二段階治療 NESKEEP®　CASE REPORT Vol.9(September, 2025) 2025
  • 秋田　真之, 柳本　泰明, 石田　潤, 南野　佳英, 浦出　剛史, 福島　健司, 小松　昇平, 浅利　貞毅, 木戸　正浩, 福本　巧：肝内胆管癌の分類は臨床的に重要か 肝胆膵 91(5):553-558 2025

PAGE TOP